Instil Bio (UK) Limited is a UK-based biotechnology company specializing in the research, development, and commercialization of innovative solutions for human health. Established in 2008, the company operates from its headquarters at Alderley Park Block 19, Macclesfield, SK10 4TF. Instil Bio is a limited company (Ltd) with a focus on providing targeted biological interventions for improved patient outcomes. The company’s core service revolves around the strategic application of biotechnology, primarily centered on the development of novel therapies and diagnostic tools. Instil Bio’s expertise spans across various areas including cell-based assays, protein engineering, and targeted drug delivery systems. Currently, Instil Bio is actively engaged in preclinical research and development, with a strong emphasis on oncology and neurological disorders. The company is dedicated to fostering international collaboration and strategic partnerships to accelerate innovation and expand its global reach. Instil Bio’s SIC codes encompass Research and experimental development on biotechnology, Human Health Activities, and potentially other related areas, including pharmaceuticals and medical devices. The company is currently rated as a Worker (A rating) under Visa, indicating a focus on strategic roles requiring significant expertise.

Instil Bio (UK) Limited is a UK-based biotechnology company specializing in the research, development, and commercialization of innovative solutions for human health. Established in 2008, the company operates from its headquarters at Alderley Park Block 19, Macclesfield, SK10 4TF. Instil Bio is a limited company (Ltd) with a focus on providing targeted biological interventions for improved patient outcomes. The company’s core service revolves around the strategic application of biotechnology, primarily centered on the development of novel therapies and diagnostic tools. Instil Bio’s expertise spans across various areas including cell-based assays, protein engineering, and targeted drug delivery systems. Currently, Instil Bio is actively engaged in preclinical research and development, with a strong emphasis on oncology and neurological disorders. The company is dedicated to fostering international collaboration and strategic partnerships to accelerate innovation and expand its global reach. Instil Bio’s SIC codes encompass Research and experimental development on biotechnology, Human Health Activities, and potentially other related areas, including pharmaceuticals and medical devices. The company is currently rated as a Worker (A rating) under Visa, indicating a focus on strategic roles requiring significant expertise.